Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma
In the current work, a simple, economical, accurate, and precise HPLC method with UV detection was developed to quantify Favipiravir (FVIR) in spiked human plasma using acyclovir (ACVR) as an internal standard in the COVID-19 pandemic time. Both FVIR and ACVR were well separated and resolved on the...
Main Authors: | Mohammad Hailat, Israa Al-Ani, Mohammed Hamad, Zainab Zakareia, Wael Abu Dayyih |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/13/3789 |
Similar Items
-
Favipiravir in Therapy of Viral Infections
by: Ryta Łagocka, et al.
Published: (2021-01-01) -
Effect of favipiravir and an anti-inflammatory strategy for COVID-19
by: Hitoshi Yamamura, et al.
Published: (2020-07-01) -
Maporal Hantavirus β-Integrin Utilization and Sensitivity to Favipiravir
by: Buys, Kristin K.
Published: (2010) -
Favipiravir: the hidden threat of mutagenic action
by: O. P. Zhirnov, et al.
Published: (2021-05-01) -
Favipiravir Use in COVID-19 Treatment
by: Emre KARA, et al.
Published: (2021-03-01)